Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.02.12
第四届董事会第十一次聚会决议通告
2018.02.12
第四届监事会第七次聚会决议通告
2018.02.12
关于收购深圳市多普乐实业生长有限公司100%股权之计划调解的说明
2018.02.12
中天堂富证券有限公司在充分尽职视察和内核的基础上出具的允许
2018.02.12
购置资产暨关联生意报告书(摘要)
2018.02.12
中天堂富证券有限公司关于公司购置资产暨关联生意之自力财务照料报告
2018.02.12
购置资产暨关联生意报告书
2018.02.12
关于召开2018年第二次暂时股东大会的通知通告
2018.02.12
使用超募资金收购深圳市多普乐实业生长有限公司100%股权的通告
2018.02.12
北京市中伦(深圳)状师事务所关于公司购置资产暨关联生意的执法意见书
第一页
上一页
57
58
59
60
61
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】